Sage Journals: Discover world-class research

Abstract

Keywords

Reporting standard trial

Get full access to this article

View all access options for this article.

References

Masic

Miokovic

Muhamedagic

. Evidence based medicine—new approaches and challenges. Acta Inform Med 2008; 16(4): 219–225.

Akobeng

. Understanding randomised controlled trials. Arch Dis Child 2005; 90(8): 840–844.

Djurisic

Rath

Gaber

, et al. Barriers to the conduct of randomised clinical trials within all disease areas. Trials 2017; 18(1): 360.

Yaseen

Hassan

Awad

, et al.

Impact of recent clinical trials on nephrology practice: Are we in a stagnant era?

Kidney Dis (Basel) 2019; 5(2): 69–80.

Strippoli

Craig

Schena

. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004; 15(2): 411–419.

Palmer

Sciancalepore

Strippoli

. Trial quality in nephrology: How are we measuring up? Am J Kidney Dis 2011; 58(3): 335–337.

Szeto

Johnson

, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int 2017; 37(2): 141–154.

Figueiredo

Bernardini

Bowes

, et al. A syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int 2016; 36(6): 592–605.

Ljungman

Jensen

Paulsen

, et al. Retraining for prevention of peritonitis in peritoneal dialysis patients: a randomized controlled trial. Perit Dial Int. Epub ahead of print 17 January 2020. DOI: 10.1177/0896860819887626.

10.

Manera

Tong

Craig

, et al. An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis. Kidney Int 2019; 96(3): 699–710.

11.

Manera

Johnson

Craig

, et al. Patient and caregiver priorities for outcomes in peritoneal dialysis: multinational nominal group technique study. Clin J Am Soc Nephrol 2019; 14(1): 74–83.

12.

Manera

Tong

Craig

, et al. Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD): study protocol for establishing a core outcome set in PD. Perit Dial Int 2017; 37(6): 639–647.

13.

Chalmers

Glasziou

. Avoidable waste in the production and reporting of research evidence. Lancet 2009; 374(9683): 86–89.

14.

Sim

Chan

Gulmezoglu

, et al. Clinical trial registration: transparency is the watchword. Lancet 2006; 367(9523): 1631–1633.

15.

Zarin

Tse

Williams

, et al. Update on trial registration 11 years after the ICMJE policy was established. N Engl J Med 2017; 376(4): 383–391.

16.

Zarin

Keselman

. Registering a clinical trial in ClinicalTrials.gov. Chest 2007; 131(3): 909–912.

17.

Wayant

Moore

Hoelscher

, et al. Adherence to reporting guidelines and clinical trial registration policies in oncology journals: a cross-sectional review. BMJ Evid Based Med 2018; 23(3): 104–110.

18.

Smith

Dworkin

RH.

Prospective clinical trial registration: not sufficient, but always necessary. Anaesthesia 2018; 73(5): 538–541.

19.

Miller

Korn

Ross

. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012. BMJ Open 2015; 5(11): e009758.

20.

Gopal

Wallach

Aminawung

, et al. Adherence to the International Committee of Medical Journal Editors’ (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals. Trials 2018; 19(1): 448.